Skip to main content

Ligand Pharmaceuticals

Ligand Pharmaceuticals Inc is an American biopharmaceutical company enabling drug development through intellectual property monetization and licensing. The company acquires and licenses rights to early-stage through commercial biopharmaceutical assets and platforms such as Captisol. Main revenue drivers comprise royalty payments on commercialized partner drugs, technology licensing fees, development milestones, and Captisol material sales. Ligand Pharmaceuticals serves global pharmaceutical companies and biotechnology developers across North America, Europe, and Asia. The company occupies a unique market position by maintaining a diversified royalty portfolio without financing internal clinical trial execution. Headquartered in San Diego, California, Ligand Pharmaceuticals Inc is listed on the Nasdaq Stock Market.

12 of the funds FundTelligence covers report a position in Ligand Pharmaceuticals.

Legal name
Ligand Pharmaceuticals Inc
Sector
Health Care
Country
United States
Funds holding it
12

Funds holding Ligand Pharmaceuticals

Showing the 8 largest of 12 funds holding it.

Loading...